Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
IASLC
Jul 2, 2024, 15:14 |
Insight
Managing dose reduction without compromising outcomes of HR+ breast cancer
Stephen V Liu shared a post on X: “At the Upstate NY Cancer Symposium, Stephanie Graff…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jun 29, 2024, 10:28 |
Blog
David R. Spigel's presentation at the 2024 ASCO on crucial developments in lung cancer treatment - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: “David R. Spigel, presentation at the…
Jun 28, 2024, 12:02 |
Blog
Herbert Loong: Regulatory Harmonisation For Oncology Clinical Trials in the APAC Region
Herbert Loong made the following post on LinkedIn: . "A shoutout again to all colleagues…
Jun 28, 2024, 11:22 |
Blog
Richard Vines: An update on the work of Rare Cancers Australia in Asia
Richard Vines, Chair - Rare Cancers Australia, made the following post on LinkedIn: .…
Jun 27, 2024, 14:02 |
Societies
Christian Rolfo named Director of Ohio State Division of Medical Oncology
Christian Rolfo, MD, PhD, MBA, Dr.hc. is Professor of Medicine (Hematology and Medical Oncology) and…
Jun 26, 2024, 14:43 |
Blog
Jonathan Spicer: Incredible pace of development for patients with resectable NSCLC
Jonathan Spicer, Medical Director of the McGill Thoracic Oncology Program, shared a post on X:…
Jun 25, 2024, 07:23 |
Blog
Dr. Herbert Loong shared his insights from ASCO24
Herbert Loong shared on LinkedIn: "Dr. Herbert Loong shared his insights on GIST-relevant presentations from the…
Jun 24, 2024, 02:03 |
Opinion
Jill Feldman: We need a shift in the Adverse Event grading system
Jill Feldman shared a post on X: “Just thinking, I strongly advocate changing the dose…
Jun 23, 2024, 10:44 |
Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
17
18
19
20
21
All:
342
Posts:
181 - 190
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Douglas Flora: The Great Wave off Kanagawa captures my feelings on certain days
Enrique Soto is running for the SIOG Board of Directors
Matti Aapro is running for the UICC Board of Directors
Facebook
RSS Feed
Twitter
Linkedin
Youtube